RxDoctor Payments Data

Eduardo Constantino, MD

Psychiatry · Stony Brook, NYNPI 1730122292

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $33,790 of the $45,707 with a category attached, or 73.9%. Johnson & Johnson accounts for 99.7% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $38,351 and has fallen 99.7% since, to $116 in 2023. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,707in general payments, 2019–2025

Across 64 payments — averaging $714.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$46K
  • Alkermes, Inc.$116

What the payments were for

  • Speaking & faculty fees$33,79074%
  • Travel & lodging$10,11222%
  • Food & beverage$1,8054%

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson63$45,591
Alkermes, Inc.1$116

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,707 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Medicare billing

Part B allowed, 2024
$71,211
Medicare patients
152
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole17$861
Clonazepam58$348
Venlafaxine Hcl ErVenlafaxine Hcl19$341
Fluoxetine Hcl16$324
Duloxetine Hcl18$270
Escitalopram Oxalate23$188
Buspirone Hcl18$141
Sertraline Hcl19$106
Mirtazapine13$65
Trazodone Hcl11$20

Paid to pharmacies, not to this prescriber.

Other psychiatry in Stony Brook

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →